Fabrication techniques for the preparation of orally administered insulin nanoparticles

References

• Bhattacharyya A, Nasim F, Mishra R, et al. Polyurethane‐incorporated chitosan/alginate core–shell nano‐particles for controlled oral insulin delivery. J Appl Polym Sci. 2018;135(26):46365.
   Web of Science ®Google Scholar
• Wong CY, Martinez J, Dass CR. Oral delivery of insulin for treatment of diabetes: Status quo, challenges and opportunities. J Pharm Pharmacol. 2016;68(9):1093–1108.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Cai H, Liu Z, et al. Effective enhancement of hypoglycemic effect of insulin by liver-targeted nanoparticles containing cholic acid-modified chitosan derivative. Mol Pharm. 2016;13(7):2433–2442.
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun M, Zheng A, et al. Preparation and characterization of insulin-loaded bioadhesive plga nanoparticles for oral administration. Eur J Pharm Sci. 2012;45(5):632–638.
   PubMed Web of Science ®Google Scholar
• Chalasani KB, Russell-Jones GJ, Yandrapu SK, et al. A novel vitamin b12-nanosphere conjugate carrier system for peroral delivery of insulin. J Control Release. 2007;117(3):421–429.
   PubMed Web of Science ®Google Scholar
• Fonte P, Nogueira T, Gehm C, et al. Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin. Drug Deliv Transl Res. 2011;1(4):299–308.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, et al. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res. 2007;24(12):2198–2206.
   PubMed Web of Science ®Google Scholar
• Lopes MA, Abrahim-Vieira B, Oliveira C, et al. Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation. Int J Nanomedicine. 2015;10:5865–5880.
   PubMed Web of Science ®Google Scholar
• Tan X, Liu X, Zhang Y, et al. Silica nanoparticles on the oral delivery of insulin. Expert Opin Drug Deliv. 2018;15(8):805–820.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. J Control Release. 2017;264:247–275.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus. Int J Pharm. 2018;549(1-2):201–217.
   PubMed Web of Science ®Google Scholar
• Du X, Zhang J, Zhang Y, et al. Decanoic acid grafted oligochitosan nanoparticles as a carrier for insulin transport in the gastrointestinal tract. Carbohydr Polym. 2014;111:433–441.
   PubMed Web of Science ®Google Scholar
• Hecq J, Siepmann F, Siepmann J, et al. Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration. Drug Dev Ind Pharm. 2015;41(12):2037–2044.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. Cellular assays and applied technologies for characterisation of orally administered protein nanoparticles: a systematic review. J Drug Target. 2020;28(6):585–599.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang Z, Bao X, et al. Fatty acid and quaternary ammonium modified chitosan nanoparticles for insulin delivery. Colloids Surf B Biointerfaces. 2018;170:136–143.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. Current status and applications of animal models in pre-clinical development of orally administered insulin-loaded nanoparticles. J Drug Target. 2020;1–22.DOI:10.1080/1061186X.2020.1759078.
   PubMed Web of Science ®Google Scholar
• Tong F, Liu S, Yan B, et al. Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/peg-cmcs preconditioning against heart ischemia/reperfusion injury in diabetes mellitus. Int J Nanomed. 2018;13:2507–2520.
   PubMed Web of Science ®Google Scholar
• Chopra S, Bertrand N, Lim JM, et al. Design of insulin-loaded nanoparticles enabled by multistep control of nanoprecipitation and zinc chelation. ACS Appl Mater Interfaces. 2017;9(13):11440–11450.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wu J, Shan W, et al. Multifunctional nanoparticles enable efficient oral delivery of biomacromolecules via improving payload stability and regulating the transcytosis pathway. ACS Appl Mater Interfaces. 2018;10(40):34039–34049.
   PubMed Web of Science ®Google Scholar
• Cui Y, Shan W, Zhou R, et al. The combination of endolysosomal escape and basolateral stimulation to overcome the difficulties of “easy uptake hard transcytosis” of ligand-modified nanoparticles in oral drug delivery. Nanoscale. 2018;10(3):1494–1507.
   PubMed Web of Science ®Google Scholar
• Shan W, Zhu X, Tao W, et al. Enhanced oral delivery of protein drugs using Zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers. ACS Appl Mater Interfaces. 2016;8(38):25444–52543.
   PubMed Web of Science ®Google Scholar
• Yang L, Li M, Sun Y, et al. A cell-penetrating peptide conjugated carboxymethyl-β-cyclodextrin to improve intestinal absorption of insulin. Int J Biol Macromol. 2018;111:685–695.
   PubMed Web of Science ®Google Scholar
• Wu J, Zheng Y, Liu M, et al. Biomimetic viruslike and charge reversible nanoparticles to sequentially overcome mucus and epithelial barriers for oral insulin delivery. ACS Appl Mater Interfaces. 2018;10(12):9916–9928.
   PubMed Web of Science ®Google Scholar
• Derakhshankhah H, Jafari S. Cell penetrating peptides: a concise review with emphasis on biomedical applications. Biomed Pharmacother. 2018;108:1090–1096. 2018/12/01/
   PubMed Web of Science ®Google Scholar
• Gessner I, Neundorf I. Nanoparticles modified with cell-penetrating peptides: conjugation mechanisms, physicochemical properties, and application in cancer diagnosis and therapy. IJMS. 2020;21(7):2536.
   Google Scholar
• Silva S, Almeida AJ, Vale N. Combination of cell-penetrating peptides with nanoparticles for therapeutic application: a review. Biomolecules. 2019;9(1):22.
   Web of Science ®Google Scholar
• Sheng J, He H, Han L, et al. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with lmwp-linked insulin conjugates. J Control Release. 2016;233:181–190.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu X, Meng L, et al. Thiolated eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Int J Pharm. 2012;436(1–2):341–350.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Du X, Zhang Y, et al. Thiolated eudragit-based nanoparticles for oral insulin delivery: Preparation, characterization, and evaluation using intestinal epithelial cells in vitro. Macromol Biosci. 2014;14(6):842–852.
   PubMed Web of Science ®Google Scholar
• Barreras-Urbina CG, Ramírez-Wong B, López-Ahumada GA, et al. Nano- and micro-particles by nanoprecipitation: possible application in the food and agricultural industries. Int J Food Prop. 2016;19(9):1912–1923.
   Web of Science ®Google Scholar
• Barichello JM, Morishita M, Takayama K, et al. Encapsulation of hydrophilic and lipophilic drugs in plga nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm. 1999;25(4):471–476.
   PubMed Web of Science ®Google Scholar
• Wong CY, Luna G, Martinez J, et al. Bio-nanotechnological advancement of orally administered insulin nanoparticles: comprehensive review of experimental design for physicochemical characterization. Int J Pharm. 2019;572:118720.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li H, Xu G, et al. Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids. Drug Deliv. 2018;25(1):1224–1233.
   PubMed Web of Science ®Google Scholar
• Faustino C, Serafim C, Rijo P, et al. Bile acids and bile acid derivatives: use in drug delivery systems and as therapeutic agents. Expert Opin Drug Deliv. 2016;13(8):1133–1148.
   PubMed Web of Science ®Google Scholar
• Tian H, He Z, Sun C, et al. Uniform core-shell nanoparticles with thiolated hyaluronic acid coating to enhance oral delivery of insulin. Adv Healthc Mater. 2018;7(17):e1800285.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Dong C, Zhao P, et al. Scalable production of therapeutic protein nanoparticles using flash nanoprecipitation. Adv Healthc Mater. 2019;8(6):e1801010.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation. J Drug Target. 2018;26(7):551–562.
   PubMed Web of Science ®Google Scholar
• Wong CY, Martinez J, Carnagarin R, et al. In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor. J Pharm Pharmacol. 2017;69(3):285–294.
   PubMed Web of Science ®Google Scholar
• Rho JG, Han HS, Han JH, et al. Self-assembled hyaluronic acid nanoparticles: implications as a nanomedicine for treatment of type 2 diabetes. J Control Release. 2018;279:89–98.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zheng Y, Wu L, et al. Novel solid lipid nanoparticle with endosomal escape function for oral delivery of insulin. ACS Appl Mater Interfaces. 2018;10(11):9315–9324.
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, et al. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm. 2007;340(1-2):153–162.
   PubMed Web of Science ®Google Scholar
• Cui F, Shi K, Zhang L, et al. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J Control Release. 2006;114(2):242–250.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. Microparticles, microcapsules and microspheres: a review of recent developments and prospects for oral delivery of insulin. Int J Pharm. 2018;537(1–2):223–244.
   PubMed Web of Science ®Google Scholar
• Jain A, Jain SK. L-valine appended plga nanoparticles for oral insulin delivery. Acta Diabetol. 2015;52(4):663–676.
   PubMed Web of Science ®Google Scholar
• Jelvehgari M, Zakeri-Milani P, Siahi-Shadbad MR, et al. Development of ph-sensitive insulin nanoparticles using eudragit l100-55 and chitosan with different molecular weights. AAPS PharmSciTech. 2010;11(3):1237–1242.
   PubMed Web of Science ®Google Scholar
• Bayrami S, Esmaili Z, SeyedAlinaghi S, et al. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (phbv) nanoparticles: Preparation, optimization, characterization, and in vitro evaluation. Pharm Dev Technol. 2019;24(2):176–188.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Mazzaglia D, Bonferoni MC, et al. Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system. Carbohyd Polym. 2011;84(3):919–925.
   Web of Science ®Google Scholar
• Sharma R, Gupta U, Garg NK, et al. Surface engineered and ligand anchored nanobioconjugate: an effective therapeutic approach for oral insulin delivery in experimental diabetic rats. Colloids Surf B Biointerfaces. 2015;127:172–181.
   PubMed Web of Science ®Google Scholar
• Hurkat P, Jain A, Jain A, et al. Concanavalin a conjugated biodegradable nanoparticles for oral insulin delivery. J Nanoparticle Res. 2012;14(11):1219.
   Web of Science ®Google Scholar
• Jain S, Rathi VV, Jain AK, et al. Folate-decorated plga nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine. 2012;7(9):1311–1337.
   PubMed Web of Science ®Google Scholar
• Boushra M, Tous S, Fetih G, et al. Development and evaluation of viscosity-enhanced nanocarrier (ven) for oral insulin delivery. Int J Pharm. 2016;511(1):462–472.
   PubMedGoogle Scholar
• Fonte P, Lino PR, Seabra V, et al. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded plga nanoparticles. Int J Pharm. 2016;503(1–2):163–173.
   PubMedGoogle Scholar
• Boushra M, Tous S, Fetih G, et al. Methocel-lipid hybrid nanocarrier for efficient oral insulin delivery. J Pharm Sci. 2016;105(5):1733–1740.
   PubMed Web of Science ®Google Scholar
• Liu X, Liu C, Zhang W, et al. Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin. Int J Pharm. 2013;448(1):159–167.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Zhang YL, Zhou JP, et al. Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin. Int J Nanomedicine. 2012;7:3333–3339.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Lv HX, Zhou JP. Novel solid lipid nanoparticles as carriers for oral administration of insulin. Pharmazie. 2009;64(9):574–578.
   PubMed Web of Science ®Google Scholar
• Chalasani KB, Russell-Jones GJ, Jain AK, et al. Effective oral delivery of insulin in animal models using vitamin b12-coated dextran nanoparticles. J Control Release. 2007;122(2):141–150.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping Q, Huang G, et al. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm. 2006;327(1–2):153–159.
   PubMed Web of Science ®Google Scholar
• Sgorla D, Lechanteur A, Almeida A, et al. Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery. Expert Opin Drug Deliv. 2018;15(3):213–222.
   PubMed Web of Science ®Google Scholar
• Czuba E, Diop M, Mura C, et al. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system. Int J Pharm. 2018;542(1-2):47–55.
   PubMed Web of Science ®Google Scholar
• Reix N, Parat A, Seyfritz E, et al. In vitro uptake evaluation in caco-2 cells and in vivo results in diabetic rats of insulin-loaded plga nanoparticles. Int J Pharm. 2012;437(1–2):213–220.
   PubMed Web of Science ®Google Scholar
• Davaran S, Omidi Y, Mohammad RR, et al. Preparation and in vitro evaluation of linear and star-branched plga nanoparticles for insulin delivery. J Bioact Compat Polym. 2008;23(2):115–131.
   Web of Science ®Google Scholar
• Sheng J, Han L, Qin J, et al. N-trimethyl chitosan chloride-coated plga nanoparticles overcoming multiple barriers to oral insulin absorption. ACS Appl Mater Interfaces. 2015;7(28):15430–15441.
   PubMed Web of Science ®Google Scholar
• Yu F, Li Y, Liu CS, et al. Enteric-coated capsules filled with mono-disperse micro-particles containing plga-lipid-peg nanoparticles for oral delivery of insulin. Int J Pharm. 2015;484(1-2):181–191.
   PubMed Web of Science ®Google Scholar
• Viehof A, Javot L, Beduneau A, et al. Oral insulin delivery in rats by nanoparticles prepared with non-toxic solvents. Int J Pharm. 2013;443(1–2):169–174.
   PubMedGoogle Scholar
• Wu ZM, Zhou L, Guo XD, et al. Hp55-coated capsule containing plga/rs nanoparticles for oral delivery of insulin. Int J Pharm. 2012;425(1–2):1–8.
   PubMed Web of Science ®Google Scholar
• Damge C, Socha M, Ubrich N, et al. Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes. J Pharm Sci. 2010;99(2):879–889.
   PubMed Web of Science ®Google Scholar
• Damge C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release. 2007;117(2):163–170.
   PubMed Web of Science ®Google Scholar
• Cui FD, Tao AJ, Cun DM, et al. Preparation of insulin loaded plga-hp55 nanoparticles for oral delivery. J Pharm Sci. 2007;96(2):421–427.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang SM, Chen PP, et al. Controlled release of insulin from plga nanoparticles embedded within pva hydrogels. J Mater Sci Mater Med. 2007;18(11):2205–2210.
   PubMed Web of Science ®Google Scholar
• Wong CY, Martinez J, Al-Salami H, et al. Quantification of bsa-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography. Anal Bioanal Chem. 2018;410(27):6991–7006.
   PubMed Web of Science ®Google Scholar
• Sun S, Liang N, Piao H, et al. Insulin-s.O (sodium oleate) complex-loaded plga nanoparticles: Formulation, characterization and in vivo evaluation. J Microencapsul. 2010;27(6):471–478.
   PubMed Web of Science ®Google Scholar
• Ristroph KD, Prud'homme RK. Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv. 2019;1(11):4207–4237.
   PubMed Web of Science ®Google Scholar
• Sun S, Liang N, Kawashima Y, et al. Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin. Int J Nanomedicine. 2011;6:3049–3056.
   PubMed Web of Science ®Google Scholar
• Sun S, Liang N, Yamamoto H, et al. Ph-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin. Int J Nanomedicine. 2015;10:3489–3498.
   PubMed Web of Science ®Google Scholar
• Elsayed AM, Khaled AH, Al Remawi MM, et al. Low molecular weight chitosan-insulin complexes solubilized in a mixture of self-assembled labrosol and plurol oleaque and their glucose reduction activity in rats. Mar Drugs. 2018;16(1):32.
   Web of Science ®Google Scholar
• Sun S, Cui F, Kawashima Y, et al. A novel insulin-sodium oleate complex for oral administration: preparation, characterization and in vivo evaluation. J Drug Deliv Sci Technol. 2008;18(4):239–243.
   Web of Science ®Google Scholar
• Avadi MR, Sadeghi AM, Mohamadpour Dounighi N, et al. Ex vivo evaluation of insulin nanoparticles using chitosan and arabic gum. ISRN Pharm. 2011;2011:860109.
   PubMedGoogle Scholar
• Lin YH, Chen CT, Liang HF, et al. Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nanotechnology. 2007;18(10):105102.
   Web of Science ®Google Scholar
• Woitiski CB, Veiga F, Ribeiro A, et al. Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin. Eur J Pharm Biopharm. 2009;73(1):25–33.
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Neufeld RJ, Ribeiro AJ, et al. Colloidal carrier integrating biomaterials for oral insulin delivery: influence of component formulation on physicochemical and biological parameters. Acta Biomater. 2009;5(7):2475–2484.
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Sharma CP. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm. 2006;325(1-2):147–154.
   PubMed Web of Science ®Google Scholar
• Sonaje K, Chen YJ, Chen HL, et al. Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials. 2010;31(12):3384–3394.
   PubMed Web of Science ®Google Scholar
• Sonaje K, Lin KJ, Wey SP, et al. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using ph-responsive nanoparticles vs. subcutaneous injection. Biomaterials. 2010;31(26):6849–6858.
   PubMed Web of Science ®Google Scholar
• Sonaje K, Lin KJ, Wang JJ, et al. Self-assembled ph-sensitive nanoparticles: a platform for oral delivery of protein drugs. Adv Funct Mater. 2010;20(21):3695–3700.
   Web of Science ®Google Scholar
• Ke Z, Guo H, Zhu X, et al. Efficient peroral delivery of insulin via vitamin b12 modified trimethyl chitosan nanoparticles. J Pharm Pharm Sci. 2015;18(2):155–170.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro AJ, Veiga F, et al. Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation. J Nanosci Nanotechnol. 2007;7(8):2833–2841.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ferreira DC, Jorgensen L, et al. Probing insulin’'s secondary structure after entrapment into alginate/chitosan nanoparticles. Eur J Pharm Biopharm. 2007;65(1):10–17.
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Neufeld RJ, Veiga F, et al. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles. Eur J Pharm Sci. 2010;41(3-4):556–563.
   PubMed Web of Science ®Google Scholar
• Jintapattanakit A, Junyaprasert VB, Mao S, et al. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharm. 2007;342(1–2):240–249.
   PubMedGoogle Scholar
• Avadi MR, Sadeghi AM, Mohammadpour N, et al. Preparation and characterization of insulin nanoparticles using chitosan and arabic gum with ionic gelation method. Nanomedicine. 2010;6(1):58–63.
   PubMed Web of Science ®Google Scholar
• Reis CP, Ribeiro AJ, Veiga F, et al. Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery. Drug Deliv. 2008;15(2):127–139.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ferreira D, Veiga F, et al. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohyd Polym. 2006;66(1):1–7.
   Web of Science ®Google Scholar
• Zhang N, Li J, Jiang W, et al. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles. Int J Pharm. 2010;393(1-2):212–218.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang Y, Yu S, et al. Dual stimuli-responsive nanoparticle-incorporated hydrogels as an oral insulin carrier for intestine-targeted delivery and enhanced paracellular permeation. ACS Biomater Sci Eng. 2018;4(8):2889–2902.
   PubMed Web of Science ®Google Scholar
• Diop M, Auberval N, Viciglio A, et al. Design, characterisation, and bioefficiency of insulin-chitosan nanoparticles after stabilisation by freeze-drying or cross-linking. Int J Pharm. 2015;491(1-2):402–408.
   PubMed Web of Science ®Google Scholar
• Li X, Guo S, Zhu C, et al. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Biomaterials. 2013;34(37):9678–9687.
   PubMed Web of Science ®Google Scholar
• Chuang EY, Lin KJ, Su FY, et al. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during ogtt in diabetic rats. J Control Release. 2013;172(2):513–522.
   PubMed Web of Science ®Google Scholar
• Pan Y, Li YJ, Zhao HY, et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm. 2002;249(1-2):139–147.
   PubMed Web of Science ®Google Scholar
• Chen S, Guo F, Deng T, et al. Eudragit s100-coated chitosan nanoparticles co-loading tat for enhanced oral colon absorption of insulin. AAPS PharmSciTech. 2017;18(4):1277–1287.
   PubMed Web of Science ®Google Scholar
• Barbari GR, Dorkoosh F, Amini M, et al. Synthesis and characterization of a novel peptide-grafted cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study. Int J Nanomedicine. 2018;13:5127–5138.
   PubMed Web of Science ®Google Scholar
• Su FY, Lin KJ, Sonaje K, et al. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials. 2012;33(9):2801–2811.
   PubMed Web of Science ®Google Scholar
• Dhanasekaran S, Rameshthangam P, Venkatesan S, et al. In vitro and in silico studies of chitin and chitosan based nanocarriers for curcumin and insulin delivery. J Polym Environ. 2018;26(10):4095–4113.
   Web of Science ®Google Scholar
• Ji N, Hong Y, Gu Z, et al. Fabrication and characterization of complex nanoparticles based on carboxymethyl short chain amylose and chitosan by ionic gelation. Food Funct. 2018;9(5):2902–2912.
   PubMed Web of Science ®Google Scholar
• Mi FL, Wu YY, Lin YH, et al. Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation. Bioconjug Chem. 2008;19(6):1248–1255.
   PubMed Web of Science ®Google Scholar
• Sonaje K, Lin YH, Juang JH, et al. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials. 2009;30(12):2329–2339.
   PubMed Web of Science ®Google Scholar
• Alfatama M, Lim LY, Wong TW. Alginate-c18 conjugate nanoparticles loaded in tripolyphosphate-cross-linked chitosan-oleic acid conjugate-coated calcium alginate beads as oral insulin carrier. Mol Pharm. 2018;15(8):3369–3382.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, et al. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules. 2007;8(10):3054–3060.
   PubMed Web of Science ®Google Scholar
• Ibie CO, Knott RM, Thompson CJ. Complexation of novel thiomers and insulin to protect against in vitro enzymatic degradation - towards oral insulin delivery. Drug Dev Ind Pharm. 2019;45(1):67–75.
   PubMed Web of Science ®Google Scholar
• Jintapattanakit A, Junyaprasert VB, Kissel T. The role of mucoadhesion of trimethyl chitosan and pegylated trimethyl chitosan nanocomplexes in insulin uptake. J Pharm Sci. 2009;98(12):4818–4830.
   PubMed Web of Science ®Google Scholar
• Liu M, Wu L, Shan W, et al. Iron-mimic peptide converts transferrin from foe to friend for orally targeting insulin delivery. J Mater Chem B. 2018;6(4):593–601.
   PubMed Web of Science ®Google Scholar
• Liu M, Zhang J, Zhu X, et al. Efficient mucus permeation and tight junction opening by dissociable “mucus-inert” agent coated trimethyl chitosan nanoparticles for oral insulin delivery. J Control Release. 2016;222:67–77.
   PubMed Web of Science ®Google Scholar
• Mahjub R, Radmehr M, Dorkoosh FA, et al. Lyophilized insulin nanoparticles prepared from quaternized n-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations. Drug Dev Ind Pharm. 2014;40(12):1645–1659.
   PubMed Web of Science ®Google Scholar
• Liu C, Kou Y, Zhang X, et al. Enhanced oral insulin delivery via surface hydrophilic modification of chitosan copolymer based self-assembly polyelectrolyte nanocomplex. Int J Pharm. 2019;554:36–47.
   PubMed Web of Science ®Google Scholar
• Ma Z, Yeoh HH, Lim LY. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J Pharm Sci. 2002;91(6):1396–1404.
   PubMed Web of Science ®Google Scholar
• Bayat A, Dorkoosh FA, Dehpour AR, et al. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: Ex vivo and in vivo studies. Int J Pharm. 2008;356(1–2):259–266.
   PubMed Web of Science ®Google Scholar
• Mao S, Bakowsky U, Jintapattanakit A, et al. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J Pharm Sci. 2006;95(5):1035–1048.
   PubMed Web of Science ®Google Scholar
• Bai X, Kong M, Xia G, et al. Systematic investigation of fabrication conditions of nanocarrier based on carboxymethyl chitosan for sustained release of insulin. Int J Biol Macromol. 2017;102:468–474.
   PubMed Web of Science ®Google Scholar
• Zhu X, Shan W, Zhang P, et al. Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery. Mol Pharm. 2014;11(1):317–328.
   PubMed Web of Science ®Google Scholar
• Shan W, Zhu X, Liu M, et al. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. Acs Nano. 2015;9(3):2345–2356.
   PubMed Web of Science ®Google Scholar
• Zhang P, Xu Y, Zhu X, et al. Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin. Int J Pharm. 2015;496(2):993–1005.
   PubMed Web of Science ®Google Scholar
• Pedroso-Santana S, Fleitas-Salazar N. Ionotropic gelation method in the synthesis of nanoparticles/microparticles for biomedical purposes. Polym Int. 2020;69(5):443–447.
   Web of Science ®Google Scholar
• Chuang EY, Lin KJ, Su FY, et al. Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery. J Control Release. 2013;169(3):296–305.
   PubMed Web of Science ®Google Scholar
• Tahtat D, Mahlous M, Benamer S, et al. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde. Int J Biol Macromol. 2013;58:160–168.
   PubMed Web of Science ®Google Scholar
• Lin YH, Mi FL, Chen CT, et al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules. 2007;8(1):146–152.
   PubMed Web of Science ®Google Scholar
• Ma Z, Lim TM, Lim LY. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int J Pharm. 2005;293(1–2):271–280.
   PubMed Web of Science ®Google Scholar
• Pan Y, Zheng JM, Zhao HY, et al. Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres. Acta Pharmacol Sin. 2002;23(11):1051–1056.
   PubMed Web of Science ®Google Scholar
• Pereira de Sousa I, Moser T, Steiner C, et al. Insulin loaded mucus permeating nanoparticles: addressing the surface characteristics as feature to improve mucus permeation. Int J Pharm. 2016;500(1–2):236–244.
   PubMedGoogle Scholar
• Zhang L, Qin H, Li J, et al. Preparation and characterization of layer-by-layer hypoglycemic nanoparticles with pH-sensitivity for oral insulin delivery. J Mater Chem B. 2018;6(45):7451–7461.
   PubMed Web of Science ®Google Scholar
• Fan YF, Wang YN, Fan YG, et al. Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption. Int J Pharm. 2006;324(2):158–167.
   PubMedGoogle Scholar
• Verma A, Sharma S, Gupta PK, et al. Vitamin b12 functionalized layer by layer calcium phosphate nanoparticles: a mucoadhesive and pH responsive carrier for improved oral delivery of insulin. Acta Biomater. 2016;31:288–300.
   PubMed Web of Science ®Google Scholar
• Bhumkar DR, Joshi HM, Sastry M, et al. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res. 2007;24(8):1415–1426.
   PubMed Web of Science ®Google Scholar
• Deng W, Xie Q, Wang H, et al. Selenium nanoparticles as versatile carriers for oral delivery of insulin: insight into the synergic antidiabetic effect and mechanism. Nanomedicine. 2017;13(6):1965–1974.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Oh J, Choo MK, et al. Chondroitin sulfate-capped gold nanoparticles for the oral delivery of insulin. Int J Biol Macromol. 2014;63:15–20.
   PubMed Web of Science ®Google Scholar
• Hosnedlova B, Kepinska M, Skalickova S, et al. Nano-selenium and its nanomedicine applications: a critical review. Int J Nanomedicine. 2018;13:2107–2128.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. Formulation and characterisation of insulin-loaded chitosan nanoparticles capable of inducing glucose uptake in skeletal muscle cells in vitro. J Drug Deliv Sci Technol. 2020;57:101738.
   Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. Lyophilisation improves bioactivity and stability of insulin-loaded polymeric-oligonucleotide nanoparticles for diabetes treatment. AAPS PharmSciTech. 2020;21(3):1–20.
   Web of Science ®Google Scholar
• Tiyaboonchai W, Woiszwillo J, Sims RC, et al. Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int J Pharm. 2003;255(1-2):139–151.
   PubMedGoogle Scholar
• Mahjub R, Dorkoosh FA, Amini M, et al. Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan. AAPS PharmSciTech. 2011;12(4):1407–1419.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Sarkar K, Chakraborty M, et al. Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model. Mater Sci Eng C Mater Biol Appl. 2013;33(1):376–382.
   PubMed Web of Science ®Google Scholar
• Makhlof A, Tozuka Y, Takeuchi H. Design and evaluation of novel ph-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci. 2011;42(5):445–451.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Martins S, Ribeiro A, et al. Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers. Int J Pept Res Ther. 2006;12(2):131–138.
   Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, et al. Development and characterization of new insulin containing polysaccharide nanoparticles. Colloids Surf B Biointerfaces. 2006;53(2):193–202.
   PubMed Web of Science ®Google Scholar
• Elsayed A, Remawi MA, Qinna N, et al. Formulation and characterization of an oily-based system for oral delivery of insulin. Eur J Pharm Biopharm. 2009;73(2):269–279.
   PubMed Web of Science ®Google Scholar
• Prusty A, Sahu SK. Development and evaluation of insulin incorporated nanoparticles for oral administration. ISRN Nanotechnol. 2013;2013:1–6.
   Google Scholar
• Nam JP, Choi C, Jang MK, et al. Insulin-incorporated chitosan nanoparticles based on polyelectrolyte complex formation. Macromol Res. 2010;18(7):630–635.
   Web of Science ®Google Scholar
• Salvioni L, Fiandra L, Del Curto MD, et al. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats. Pharmacol Res. 2016;110:122–130.
   PubMed Web of Science ®Google Scholar
• Shamsa ES, Mahjub R, Mansoorpour M, et al. Nanoparticles prepared from n,n-dimethyl-n-octyl chitosan as the novel approach for oral delivery of insulin: preparation, statistical optimization and in-vitro characterization. Iran J Pharm Res. 2018;17(2):442–459.
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Sarmento B, Carvalho RA, et al. Facilitated nanoscale delivery of insulin across intestinal membrane models. Int J Pharm. 2011;412(1–2):123–131.
   PubMed Web of Science ®Google Scholar
• Burova TV, Grinberg NV, Tur DR, et al. Ternary interpolyelectrolyte complexes insulin-poly(methylaminophosphazene)-dextran sulfate for oral delivery of insulin. Langmuir. 2013;29(7):2273–2281.
   PubMed Web of Science ®Google Scholar
• Andreani T, Miziara L, Lorenzon EN, et al. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: interactions with mucin and biomembrane models. Eur J Pharm Biopharm. 2015;93:118–126.
   PubMed Web of Science ®Google Scholar
• Andreani T, de Souza AL, Kiill CP, et al. Preparation and characterization of peg-coated silica nanoparticles for oral insulin delivery. Int J Pharm. 2014;473(1–2):627–635.
   PubMed Web of Science ®Google Scholar
• Bharti C, Nagaich U, Pal AK, et al. Mesoporous silica nanoparticles in target drug delivery system: a review. Int J Pharm Investig. 2015;5(3):124–133.
   PubMed Web of Science ®Google Scholar
• Zhao X, Shan C, Zu Y, et al. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin. Int J Pharm. 2013;454(1):278–284.
   PubMedGoogle Scholar
• Guha A, Biswas N, Bhattacharjee K, et al. pH responsive cylindrical msn for oral delivery of insulin-design, fabrication and evaluation. Drug Deliv. 2016;23(9):3552–3561.
   PubMed Web of Science ®Google Scholar
• Wong CY, Martinez J, Zhao J, et al. Development of orally administered insulin-loaded polymeric-oligonucleotide nanoparticles: statistical optimization and physicochemical characterization. Drug Dev Ind Pharm. 2020;46(8):1238–1252.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage. J Pharm Pharmacol. 2020.DOI:10.1111/jphp.13359.
   Web of Science ®Google Scholar